Spinal Tech

Zacks restated their neutral rating on shares of Stryker in a new report, according to an Intercooler Online report.

OrthAlign received CE Mark approval to market its OrthAlign Plus system.

Baird upgraded Zimmer to "outperform" from "neutral," according to a Rock Hill Daily report.

SpineGuard received FDA clearance on the PediGuard products for minimally invasive spine surgery.

Misonix acquired back the rights to the remaining accounts for the Misonix BoneScalpel Ultrasonic Bone Cutting System from Aesculap.

Precision Spine reported double-digit growth for the fifth consecutive year in 2014.

Medical device industry advocates AdvaMed, along with large device companies, have spent considerable resources lobbying against the medical device excise tax and then lobbying for repeal, and with the new Republican-controlled Congress they just might get it.

MedShape received clearance from the Food and Drug Administration for the FastForward Bone Tether Plate.

ChoiceSpine acquired the Baxano VEO Lateral Access & Interbody Fusion System.

Stryker shares dropped 1.78 percent over the over the past week and 3.13 percent over the past four weeks, according to a Winston View report.